+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Interventional Oncology Global Market - Forecast to 2026

  • ID: 5007784
  • Report
  • March 2020
  • Region: Global
  • 403 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 4
The Interventional Oncology Global Market is Expected to Grow at a High Single Digit CAGR from 2019 to 2026 to Reach $2,119.4 Million by 2026

FEATURED COMPANIES

  • ABK Biomedical Inc.
  • Erbe Elktromedizin GmbH
  • IMBiotechnologies
  • MedWaves Medical
  • Monteris Medical Inc
  • Sanarus Medical
  • MORE

Interventional Oncology (I.O.) is a rapidly growing field in cancer care that uses minimally invasive procedures performed under image guidance to diagnose and treat patients with liver, kidney, lung, and other cancers. Rather than removing tumors through open surgical procedures, these image-guided procedures can be performed in place of or in combination with other cancer treatments to provide truly comprehensive care. The advantage of these methods is that I.O. has much less effect on the body compared to conventional procedures.

An estimated by the publisher, the interventional oncology global market is expected to grow at a high single digit CAGR from 2019 to 2026 to reach $2,119.4 million by 2026. Some of the factors driving the market are increasing prevalence of cancer cases, growing adoption of minimally invasive procedures, increasing geriatric population, technological advancements in the field of interventional oncology, and expansion in the emerging markets.

The interventional oncology market by product is segmented as ablation and embolization. The embolization segment holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026. The ablation segment is the fastest-growing segment with a high single digit CAGR from 2019 to 2026.

Ablation global market by product type, it is segmented into radiofrequency ablation, microwave ablation, cryoablation and others (irreversible electroporation and MRI-guided laser ablation). Among ablation, microwave ablation holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026. The other segment is the fastest-growing segment with a high double digit CAGR from 2019 to 2026.

Embolization global market by product type, it is segmented into Radio-embolization and non-radioembolization. Among embolization, non-radioembolization holds the highest revenue in 2019 and it is expected to grow at a mid single digit CAGR from 2019 to 2026. The radio-embolization segment is the fastest-growing segment with a high single digit CAGR from 2019 to 2026. The embolization global market by procedure, it is segmented into trans-arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), transcranial chemo-embolization (TACE), drug-eluting beads transcranial chemo-embolization (DEB-TACE) and transcranial embolization (TAE)/bland embolization. Among procedures, TARE/SIRT segment is the fastest-growing segment with a high single digit CAGR from 2019 to 2026.

Interventional Oncology (I.O.) global market by application is segmented into liver cancer, kidney cancer, lung cancer, brain & spine cancer, prostate cancer, uterine fibroid and others. Among interventional oncology applications, the liver cancer segment holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026. The brain & spine cancer segment is the fastest-growing segment with a low double digit CAGR from 2019 to 2026.

Ablation global market by application is segmented into liver cancer, kidney cancer, lung cancer, brain & spine cancer, prostate cancer, and others. Among ablation applications, the liver cancer segment holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026. The brain & spine cancer segment is the fastest-growing segment with a low double digit CAGR from 2019 to 2026. Embolization global market by application is segmented into liver cancer, lung cancer, prostate cancer, uterine fibroid and other. Among embolization applications, the liver cancer segment holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026. The uterine fibroid segment is the fastest-growing segment with a high single digit CAGR from 2019 to 2026.

Interventional Oncology global market by end-users is segmented into hospitals, ambulatory surgical centers (ASC), academics & research institutes. Among end-users, the hospital segment holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026. The ambulatory surgical center segment is the fastest-growing segment with a high single digit CAGR from 2019 to 2026.

Interventional oncology market by region is segmented as North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (China, Japan, Australia and Rest of APAC) and Rest of the world (Brazil, Rest of LATAM and Middle East & Others). North America holds the highest revenue in 2019 and it is expected to grow at a high single digit CAGR from 2019 to 2026 due to adoption of the technological advancements, increasing incidences of cancer, increased training institutes for interventional oncology, increasing demand for minimally invasive surgeries, favorable reimbursement, product launches, skilled personnel, and strong product pipeline. The Asia-Pacific region is the fastest-growing region with a low double digit CAGR from 2019 to 2026 due to increasing geriatric population, increased healthcare facilities, increasing incidence of cancer, increasing awareness about interventional oncology and low-cost for the surgery are driving the market.

The interventional oncology global market is a consolidated market with top 5 players occupying major share of the market hence all the existing players in this market are involved in developing new and advanced therapeutics to maintain their market shares. Some of the major players in interventional oncology market include Medtronic Plc (Ireland), Sirtex Medical (Australia), Boston Scientific Corporation (U.S.), Guerbet (France), Merit Medical System (U.S.), Varian Medical System, Inc. (U.S.), Terumo Corporation (Japan), Johnson & Johnson (U.S.), AngioDynamics, Inc. (U.S.), and Monteris Medical (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of LATAM
  • Middle East and Others
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABK Biomedical Inc.
  • Erbe Elktromedizin GmbH
  • IMBiotechnologies
  • MedWaves Medical
  • Monteris Medical Inc
  • Sanarus Medical
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown and Data Triangulation
2.6.3 Secondary Sources
2.6.4 Primary Sources
2.6.5 Key Data Points from Secondary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increasing Prevalence of Cancer Cases
3.3.1.2 Growing Adoption of Minimally Invasive Procedures
3.3.1.3 Increasing Geriatric Population
3.3.1.4 Technological Advancements in the Field of Interventional Oncology
3.3.1.5 Expansion in the Emerging Markets
3.3.2 Restraints and Threats
3.3.2.1 Side Effects and Risks Associated with the Use
3.3.2.2 Lack of Awareness and Understanding About Interventional Oncology Importance
3.3.2.3 Lack of Trained Professionals
3.3.2.4 Availability of Alternative Treatments
3.3.2.5 Stringent Regulatory Guidelines
3.4 Regulatory Affairs
3.4.1 International Organization For Standardization
3.4.1.1 Iso 9001: 2015 Quality Management System
3.4.1.2 Iso 13485 Medical Devices
3.4.1.3 Iso 10993 Biological Evaluation of Medical Devices
3.4.1.4 Iso 14971 Risk Management of Medical Devices
3.4.1.5 Iso 12807:2018 Safe Transport of Radioactive Materials-Leakage Testing On Packages
3.4.1.6 Iec 60601-1 Medical Electrical Equipment Standard
3.4.1.7 Iec 60601-1-2 Electromagnetic Compatibility (Emc) For Medical Devices
3.4.2 U.S.
3.4.3 Canada
3.4.4 Europe
3.4.5 Japan
3.4.6 China
3.4.7 India
3.5 Clinical Trials Data
3.6 Porter’s Five Force Analysis
3.6.1 Threat of New Entrants
3.6.2 Threat of Substitutes
3.6.3 Bargaining Power of Suppliers
3.6.4 Bargaining Power of Buyers
3.6.5 Competitive Rivalry
3.7 Supply Chain Analysis
3.8 Reimbursement Scenario
3.9 Regulatory Approved Interventional Oncology Products by Company
3.10 Funding Scenario
3.11 Market Share Analysis by Major Players
3.11.1 Interventional Oncology Global Market Share Analysis
3.11.2 Ablation Global Market Share Analysis
3.11.3 Embolization Global Market Share Analysis
3.12 Interventional Oncology Number of Units by Region
3.12.1 Ablation Devices Number of Units by Region
3.12.2 Radiofrequency Ablation Devices Number of Units by Region
3.12.3 Microwave Ablation Devices Number of Units by Region
3.12.4 Cryoablation Devices Number of Units by Region
3.13 Interventional Oncology Procedure Volume by Product Type
3.14 Market Penetration of Interventional Oncology by Application
3.15 Interventional Oncology Company Comparison Table by Revenue, Product and Application

4 Interventional Oncology Global Market, by Product
4.1 Introduction
4.2 Ablation
4.2.1 Radiofrequency Ablation
4.2.2 Microwave Ablation
4.2.3 Cryoablation Ablation
4.2.4 Other Ablation
4.3 Embolization
4.3.1 Embolization by Product Type
4.3.1.1 Radio-Embolization
4.3.1.2 Non-Radioembolization
4.3.2 Embolization by Procedure
4.3.2.1 Transarterial Radio-Embolization (TARE)/Selective Internal Radiation Therapy (SIRT)
4.3.2.2 Transarterial Chemo-Embolization (TACE)
4.3.2.3 Drug-Eluting Beads Transarterial Chemo-Embolization (DEB-TACE)
4.3.2.4 Bland Embolization/ Transarterial Embolization (TAE)

5 Interventional Oncology Global Market, by Application
5.1 Introduction
5.1.1 Liver Cancer
5.1.2 Kidney Cancer
5.1.3 Lung Cancer
5.1.4 Brain and Spine Cancer
5.1.5 Prostate Cancer
5.1.6 Uterine Fibroids
5.1.7 Other Applications

6 Interventional Oncology Global Market, by End-Users
6.1 Introduction
6.1.1 Hospitals
6.1.2 Ambulatory Surgical Centers (ASC’s)
6.1.3 Academics and Research Institutes

7 Regional Analysis
7.1 Introduction
7.2 North America
7.2.1 U.S.
7.2.2 Rest of North America
7.3 Europe
7.3.1 Germany
7.3.2 France
7.3.3 Italy
7.3.4 Rest of Europe
7.4 APAC
7.4.1 China
7.4.2 Japan
7.4.3 Australia
7.4.4 Rest of APAC
7.5 RoW
7.5.1 Brazil
7.5.2 Rest of LATAM
7.5.3 Middle East & Others

8 Competitive Landscape
8.1 Introduction
8.2 Product Approval
8.3 Acquisition and Partnership
8.4 New Product Launch
8.5 Others

9 Major Companies
9.1 Angiodynamics Inc.
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Key Developments
9.1.5 Business Strategy
9.1.6 SWOT Analysis
9.2 Boston Scientific Corporation
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Key Developments
9.2.5 Business Strategy
9.2.6 SWOT Analysis
9.3 Guerbet
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Key Developments
9.3.5 Business Strategy
9.3.6 SWOT Analysis
9.4 Johnson & Johnson
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Key Developments
9.4.5 Business Strategy
9.4.6 SWOT Analysis
9.5 Medtronic Plc
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Key Developments
9.5.5 Business Strategy
9.5.6 SWOT Analysis
9.6 Merit Medical Systems, Inc.
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Key Developments
9.6.5 Business Strategy
9.6.6 SWOT Analysis
9.7 Monteris Medical
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Key Developments
9.7.5 Business Strategy
9.7.6 SWOT Analysis
9.8 Sirtex Medical Limited
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Key Developments
9.8.5 Business Strategy
9.8.6 SWOT Analysis
9.9 Terumo Corporation
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Key Developments
9.9.5 Business Strategy
9.9.6 SWOT Analysis
9.10 Varian Medical System Inc.
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Key Developments
9.10.5 Business Strategy
9.10.6 SWOT Analysis

List of Tables
Table 1 Interventional Oncology Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 2 Ablation Devices Number of Units, by Region, (2018-2026) (No’s)
Table 3 Radiofrequency Ablation Devices Number of Units, by Region, (2018-2026) (No’s)
Table 4 Microwave Ablation Devices Number of Units, by Region, (2018-2026) (No’s)
Table 5 Cryoablation Devices Number of Units, by Region, (2018-2026) (No’s)
Table 6 Ablation Global Procedure Volume, by Product Type, (2018-2026) (No’s)
Table 7 Embolization Global Procedure Volume, by Product Type, (2018-2026) (No’s)
Table 8 Interventional Oncology Global Market Revenue, by Product, (2018-2026) ($Mn)
Table 9 Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 10 Ablation Global Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 11 Radiofrequency Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 12 Microwave Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 13 Cryoablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 14 Other Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 15 Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 16 Embolization Global Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 17 Radio-Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 18 Non-Radioembolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 19 Embolization Global Market Revenue, by Procedure, (2018-2026) ($Mn)
Table 20 Transarterial Radio-Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 21 Transarterial Chemo-Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 22 Deb-Tace Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 23 Tae Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 24 Interventional Oncology Global Market Revenue, by Application, (2018-2026) ($Mn)
Table 25 Ablation Global Market Revenue, by Application, (2018-2026) ($Mn)
Table 26 Embolization Global Market Revenue, by Application, (2018-2026) ($Mn)
Table 27 Liver Cancer Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 28 Liver Cancer Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 29 Liver Cancer Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 30 Kidney Cancer Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 31 Lung Cancer Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 32 Lung Cancer Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 33 Lung Cancer Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 34 Brain & Spine Cancer Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 35 Prostate Cancer Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 36 Prostate Cancer Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 37 Prostate Cancer Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 38 Uterine Fibroids Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 39 Other Cancer Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 40 Other Cancer Ablation Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 41 Other Cancer Embolization Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 42 Interventional Oncology Global Market Revenue, by End-Users, (2018-2026) ($Mn)
Table 43 Hospitals Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 44 Ambulatory Surgical Centers Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 45 Academics and Research Institues Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 46 Interventional Oncology Global Market Revenue, by Region, (2018-2026) ($Mn)
Table 47 North America Interventional Oncology Market Revenue, by Product, (2018-2026) ($Mn)
Table 48 North America Ablation Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 49 North America Embolization Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 50 North America Embolization Market Revenue, by Procedure, (2018-2026) ($Mn)
Table 51 North America Interventional Oncology Market Revenue, by Application, (2018-2026) ($Mn)
Table 52 North America Ablation Market Revenue, by Application, (2018-2026) ($Mn)
Table 53 North America Embolization Market Revenue, by Application, (2018-2026) ($Mn)
Table 54 North America Interventional Oncology Market Revenue, by End-User, (2018-2026) ($Mn)
Table 55 North America Interventional Oncology Market Revenue, by Country, (2018-2026) ($Mn)
Table 56 Europe Interventional Oncology Market Revenue, by Product, (2018-2026) ($Mn)
Table 57 Europe Ablation Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 58 Europe Embolization Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 59 Europe Embolization Market Revenue, by Procedure, (2018-2026) ($Mn)
Table 60 Europe Interventional Oncology Market Revenue, by Application, (2018-2026) ($Mn)
Table 61 Europe Ablation Market Revenue, by Application, (2018-2026) ($Mn)
Table 62 Europe Embolization Market Revenue, by Application, (2018-2026) ($Mn)
Table 63 Europe Interventional Oncology Market Revenue, by End-User, (2018-2026) ($Mn)
Table 64 Europe Interventional Oncology Market Revenue, by Country, (2018-2026) ($Mn)
Table 65 APAC Interventional Oncology Market Revenue, by Product, (2018-2026) ($Mn)
Table 66 APAC Ablation Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 67 APAC Embolization Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 68 APAC Embolization Market Revenue, by Procedure, (2018-2026) ($Mn)
Table 69 APAC Interventional Oncology Market Revenue, by Application, (2018-2026) ($Mn)
Table 70 APAC Ablation Market Revenue, by Application, (2018-2026) ($Mn)
Table 71 APAC Embolization Market Revenue, by Application, (2018-2026) ($Mn)
Table 72 APAC Interventional Oncology Market Revenue, by End-User, (2018-2026) ($Mn)
Table 73 APAC Interventional Oncology Market Revenue, by Country, (2018-2026) ($Mn)
Table 74 RoW Interventional Oncology Market Revenue, by Product, (2018-2026) ($Mn)
Table 75 RoW Ablation Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 76 RoW Embolization Market Revenue, by Product Type, (2018-2026) ($Mn)
Table 77 RoW Embolization Market Revenue, by Procedure, (2018-2026) ($Mn)
Table 78 RoW Interventional Oncology Market Revenue, by Application, (2018-2026) ($Mn)
Table 79 RoW Ablation Market Revenue, by Application, (2018-2026) ($Mn)
Table 80 RoW Embolization Market Revenue, by Application, (2018-2026) ($Mn)
Table 81 RoW Interventional Oncology Market Revenue, by End-User, (2018-2026) ($Mn)
Table 82 RoW Interventional Oncology Market Revenue, by Country, (2018-2026) ($Mn)
Table 83 Product Approval (2017-2019)
Table 84 Acquisition and Partnership (2017-2020)
Table 85 New Product Launch (2017-2019)
Table 86 Others (2017-2019)
Table 87 Angiodynamics, Inc.: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 88 Angiodynamics, Inc.: Total Revenue, by Segment, (2017-2019) ($Mn)
Table 89 Angiodynamics, Inc.: Total Revenue, by Geography, (2017-2019) ($Mn)
Table 90 Boston Scientific Corporation: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 91 Boston Scientific Corporation: Total Revenue, by Segments, (2017-2019) ($Mn)
Table 92 Boston Scientific Corporation: Total Revenue, by Geography, (2017-2019) ($Mn)
Table 93 Guerbet: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 94 Guerbet: Total Revenue, by Segment, (2017-2019) ($Mn)
Table 95 Guerbet: Total Revenue, by Geography, (2017-2019) ($Mn)
Table 96 Johnson & Johnson: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 97 Johnson & Johnson: Total Revenue, by Segment, (2017-2019) ($Mn)
Table 98 Johnson & Johnson: Total Revenue, by Geography, (2017-2019) ($Mn)
Table 99 Medtronic Plc: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 100 Medtronic Plc:Total Revenue, by Segment, (2017-2019) ($Mn)
Table 101 Medtronic Plc: Minimally Invasive Therapies Group Revenue, by Sub-Segment, (2017-2019) ($Mn)
Table 102 Medtronic Plc:Total Revenue, by Geography, (2017-2019) ($Mn)
Table 103 Merit Medical System, Inc.: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 104 Merit Medical System, Inc: Total Revenue, by Segments, (2017-2019) ($Mn)
Table 105 Merit Medical System, Inc: Total Revenue, by Cardivascular Sub-Segment, (2017-2019) ($Mn)
Table 106 Merit Medical System, Inc.: Total Revenue, by Geography, (2017-2019) ($Mn)
Table 107 Terumo Corporation: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 108 Terumo Corporation: Total Revenue, by Segment, (2017-2019) ($Mn)
Table 109 Terumo Corporation: Total Revenue, by Geography, (2017-2019) ($Mn)
Table 110 Varian Medical System Inc.: Total Revenue and R&D Expenses, (2017-2019) ($Mn)
Table 111 Varian Medical System Inc.: Total Revenue, by Segment, (2017-2019) ($Mn)
Table 112 Varian Medical System Inc.: Total Revenue, by Geography, (2017-2019) ($Mn)

List of Figures
Figure 1 Interventional Oncology Global Market Revenue, by Region (2018-2026) ($Mn)
Figure 2 Research Methodology: Interventional Oncology Global Market
Figure 3 Interventional Oncology Global Market: Top-Down and Bottom-Up Approach
Figure 4 Interventional Oncology Global Market: Forecasting Model
Figure 5 Interventional Oncology Global Market: Market Breakdown and Data Triangulation
Figure 6 Interventional Oncology Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Interventional Oncology Clinical Trial (2018-2019)
Figure 9 Interventional Oncology Global Market: Porter’s Analysis
Figure 10 Interventional Oncology: Supply Chain Analysis
Figure 11 Interventional Oncology Global Market Share Analysis, by Key Players, 2019 (%)
Figure 12 Ablation Global Market Share Analysis, by Key Players, 2019 (%)
Figure 13 Embolization Global Market Share Analysis, by Key Players, 2019 (%)
Figure 14 Ablation Devices Number of Units, by Product Type, (2018-2026) (No’s)
Figure 15 Radiofrequency Ablation Devices Number of Units, by Region (2019) (No’s)
Figure 16 Microwave Ablation Devices Number of Units, by Region (2019) (No’s)
Figure 17 Cryoablation Devices Number of Units, by Region (2019) (No’s)
Figure 18 Liver, Kidney, Lung, Prostate, Brain & Spine Cancer Market Penetration in Interventional Oncology Global Market, 2019 (%)
Figure 19 Interventional Oncology Global Market Share, by Product (2019 V/S 2026) (%)
Figure 20 Ablation Global Market Share, by Product Type (2019 V/S 2026) (%)
Figure 21 Embolization Global Market Share, by Product Type (2019 V/S 2026) (%)
Figure 22 Embolization Global Market Share, by Procedure (2019 V/S 2026) (%)
Figure 23 Interventional Oncology Global Market Share, by Application (2019 V/S 2026) (%)
Figure 24 Ablation Global Market Share, by Application (2019 V/S 2026) (%)
Figure 25 Embolization Global Market Share, by Application (2019 V/S 2026) (%)
Figure 26 Interventional Oncology Global Market Share, by End-Users (2019 V/S 2026) (%)
Figure 27 Interventional Oncology Global Market Revenue, by Region (2018-2026) ($Mn), Cagr (%)
Figure 28 Interventional Oncology Global Market Share, by Geography (2019) (%)
Figure 29 North America Interventional Oncology Market Share, by Product, Ablation and Embolization Market Share, by Product Type (2019 V/S 2026) (%)
Figure 30 North America Embolization Market Share, by Procedure (2019 V/S 2026) (%)
Figure 31 North America Interventional Oncology Market Share, by Application, Ablation and Embolization Market Share, by Application (2019 V/S 2026) (%)
Figure 32 North America Interventional Oncology Market Share, by End-User (2019 V/S 2026) (%)
Figure 33 North America Interventional Oncology Market Share, by Country (2019 V/S 2026) (%)
Figure 34 U.S. Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 35 U.S. Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 36 U.S. Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 37 U.S. Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 38 Rest of North America Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 39 Rest of North America Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 40 Rest of North America Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 41 Rest of North America Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 42 Europe Interventional Oncology Market Share, by Product, Ablation and Embolization Market Share, by Product Type (2019 V/S 2026) (%)
Figure 43 Europe Embolization Market Share, by Procedure (2019 V/S 2026) (%)
Figure 44 Europe Interventional Oncology Market Share, by Application, Ablation and Embolization Market Share, by Application (2019 V/S 2026) (%)
Figure 45 Europe Interventional Oncology Market Share, by End-User (2019 V/S 2026) (%)
Figure 46 Europe Interventional Oncology Market Share, by Country (2019 V/S 2026) (%)
Figure 47 Germany Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 48 Germany Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 49 Germany Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 50 Germany Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 51 France Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 52 France Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 53 France Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 54 France Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 55 Italy Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 56 Italy Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 57 Italy Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 58 Italy Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 59 Rest of Europe Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 60 Rest of Europe Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 61 Rest of Europe Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 62 Rest of Europe Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 63 APAC Interventional Oncology Market Share, by Product, Ablation and Embolization Market Share, by Product Type (2019 V/S 2026) (%)
Figure 64 APAC Embolization Market Share, by Procedure (2019 V/S 2026) (%)
Figure 65 APAC Interventional Oncology Market Share, by Application, Ablation and Embolization Market Share, by Application (2019 V/S 2026) (%)
Figure 66 APAC Interventional Oncology Market Share, by End-User (2019 V/S 2026) (%)
Figure 67 APAC Interventional Oncology Market Share, by Country (2019 V/S 2026) (%)
Figure 68 China Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 69 China Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 70 China Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 71 China Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 72 Japan Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 73 Japan Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 74 Japan Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 75 Japan Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 76 Australia Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 77 Australia Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 78 Australia Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 79 Australia Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 80 Rest of APAC Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 81 Rest of APAC Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 82 Rest of APAC Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 83 Rest of APAC Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 84 RoW Interventional Oncology Market Share, by Product, Ablation and Embolization Market Share, by Product Type (2019 V/S 2026) (%)
Figure 85 RoW Embolization Market Share, by Procedure (2019 V/S 2026) (%)
Figure 86 RoW Interventional Oncology Market Share, by Application, Ablation and Embolization Market Share, by Application (2019 V/S 2026) (%)
Figure 87 RoW Interventional Oncology Market Share, by End-User (2019 V/S 2026) (%)
Figure 88 RoW Interventional Oncology Market Share, by Country (2019 V/S 2026) (%)
Figure 89 Brazil Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 90 Brazil Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 91 Brazil Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 92 Brazil Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 93 Rest of LATAM Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 94 Rest of LATAM Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 95 Rest of LATAM Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 96 Rest of LATAM Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 97 Middle East & Others Interventional Oncology Market Revenue, by Product, Ablation and Embolization Market Revenue, by Product Type (2019 V/S 2026) ($Mn)
Figure 98 Middle East & Others Embolization Market Revenue, by Procedure (2019 V/S 2026) ($Mn)
Figure 99 Middle East & Others Interventional Oncology Market Revenue, by Application, Ablation and Embolization Market Revenue, by Application (2019 V/S 2026) ($Mn)
Figure 100 Middle East & Others Interventional Oncology Market Revenue, by End-User (2019 V/S 2026) ($Mn)
Figure 101 Key Growth Strategies, (2017-2020)
Figure 102 SWOT: Angiodynamics, Inc.
Figure 103 SWOT: Boston Scientific Corporation
Figure 104 SWOT: Guerbet
Figure 105 SWOT: Johnson & Johnson
Figure 106 SWOT: Medtronic Plc
Figure 107 SWOT: Merit Medical System, Inc.
Figure 108 SWOT: Monteris Medical
Figure 109 SWOT: Sirtex Medical
Figure 110 SWOT: Terumo Corporation
Figure 111 SWOT: Varian Medical System Inc.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ABK Biomedical Inc.
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Clinical Laserthermia Systems
  • Delcath Systems, Inc
  • Erbe Elktromedizin GmbH
  • Guerbet
  • IceCure Medical
  • IMBiotechnologies
  • Johnson & Johnson
  • Medtronic Plc
  • MedWaves Medical
  • Merit Medical System
  • Misonix
  • Monteris Medical Inc
  • Profound Medical Corp.
  • Royal Phillips
  • Sanarus Medical
  • Sirtex Medical
  • SonaCare Medical LLC
  • Terumo Corporation
  • Trod Medical
  • Varian Medical System
Note: Product cover images may vary from those shown
Adroll
adroll